Table 5.
Candidate SNP markers associated with the malignancy grade of MGT derived from the linear regression test.
Marker | Chromosome | Position | Gene | Variant | Allele (M > m) |
MAF | Major Homo (mean) |
Hetero (mean) |
Minor Homo (mean) |
P value† | R value† | P value‡ | Slope‡ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BICF2S23436248 | 34 | 22,547,748 | IL1RAP | Exon | A > G | 0.385 | 9(2.00) | 8(1.13) | 4(0.00) | 0.002 | 0.574 | 0.0002 | −1.088 |
BICF2P605684 | 8 | 70,488,402 | MOK | Exon | G > A | 0.219 | 14(0.71) | 5(2.40) | 2(2.50) | 0.003 | 0.558 | 0.0002 | 1.212 |
SNP, single-nucleotide polymorphism; MGT, mammary gland tumor; M > m, major allele to minor allele; MAF, minor allele frequency. †Correlation/trend; ‡Linear regression. (Genome-wide significance level: α′ = 3.94×10−7).